tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

RVMD Stock Latest News

Revolution Medicines doses first patient in trial evaluating RMC-5127
The FlyRevolution Medicines doses first patient in trial evaluating RMC-5127
1d ago
RVMD
Revolution Medicines price target raised to $150 from $75 at Oppenheimer
PremiumThe Fly
Revolution Medicines price target raised to $150 from $75 at Oppenheimer
3d ago
RVMD
Revolution Medicines: Differentiated RAS(ON) Pipeline Underpins Overweight/Buy Rating and $92 December 2026 Target
PremiumRatings
Revolution Medicines: Differentiated RAS(ON) Pipeline Underpins Overweight/Buy Rating and $92 December 2026 Target
4d ago
RVMD
Revolution Medicines falls -17.1%
PremiumThe Fly
Revolution Medicines falls -17.1%
4d ago
RVMD
Revolution Medicines Advances RMC-5127 KRAS Program, Extending Its Oncology Reach
PremiumCompany Announcements
Revolution Medicines Advances RMC-5127 KRAS Program, Extending Its Oncology Reach
4d ago
RVMD
Revolution Medicines falls -19.7%
PremiumThe FlyRevolution Medicines falls -19.7%
4d ago
RVMD
Morning Movers: USA Rare Earth surges after government funding pact
Premium
The Fly
Morning Movers: USA Rare Earth surges after government funding pact
4d ago
AAUC
CRWV
Video: Precious metal stocks keep rising as gold surges above $5,000 an ounce
Premium
The Fly
Video: Precious metal stocks keep rising as gold surges above $5,000 an ounce
4d ago
B
CDE
JPMorgan sees Revolution trading ‘meaningfully lower’ on WSJ report
PremiumThe Fly
JPMorgan sees Revolution trading ‘meaningfully lower’ on WSJ report
5d ago
RVMD
M&A News: Revolution Medicines (RVMD) Stock Plunges as Merck Ends Takeover Talks on Price Disagreement
PremiumMarket News
M&A News: Revolution Medicines (RVMD) Stock Plunges as Merck Ends Takeover Talks on Price Disagreement
5d ago
MRK
ABBV
Revolution Medicines: Post‑Merger Volatility Creates Compelling Entry Point Ahead of Blockbuster PDAC Opportunity and 2026 Catalysts
PremiumRatings
Revolution Medicines: Post‑Merger Volatility Creates Compelling Entry Point Ahead of Blockbuster PDAC Opportunity and 2026 Catalysts
5d ago
RVMD
Revolution Medicines buyers will step in on weakness, says Stifel
PremiumThe Fly
Revolution Medicines buyers will step in on weakness, says Stifel
5d ago
MRK
RVMD
Merck no longer in talks to acquire Revolution Medicines, WSJ reports
PremiumThe FlyMerck no longer in talks to acquire Revolution Medicines, WSJ reports
5d ago
MRK
RVMD
Revolution Medicines price target raised to $170 from $85 at Stifel
Premium
The Fly
Revolution Medicines price target raised to $170 from $85 at Stifel
8d ago
RVMD
Revolution Medicines price target raised to $140 from $77 at RBC Capital
Premium
The Fly
Revolution Medicines price target raised to $140 from $77 at RBC Capital
10d ago
RVMD
Revolution Medicines price target raised to $160 from $92 at Guggenheim
PremiumThe Fly
Revolution Medicines price target raised to $160 from $92 at Guggenheim
10d ago
RVMD
Private Markets: SpaceX interviews banks to lead IPO, Skild AI raises $1.4B
PremiumThe Fly
Private Markets: SpaceX interviews banks to lead IPO, Skild AI raises $1.4B
14d ago
V
MA
Expanding RAS-Targeted Franchise and Late-Stage Pipeline Drive Buy Rating on Revolution Medicines
PremiumRatings
Expanding RAS-Targeted Franchise and Late-Stage Pipeline Drive Buy Rating on Revolution Medicines
15d ago
RVMD
Merck Sees $70B Revenue Potential From New Growth Drivers by Mid-2030s
PremiumMarket News
Merck Sees $70B Revenue Potential From New Growth Drivers by Mid-2030s
17d ago
MRK
RVMD
Revolution Medicines: Clinical Momentum and Strategic Phase 3 Design Support Buy Rating on RVMD
PremiumRatingsRevolution Medicines: Clinical Momentum and Strategic Phase 3 Design Support Buy Rating on RVMD
17d ago
RVMD
Revolution Medicines price target raised to $143 from $90 at Mizuho
Premium
The Fly
Revolution Medicines price target raised to $143 from $90 at Mizuho
18d ago
RVMD
Revolution Medicines: Dominant Pancreatic Cancer Position, Expanding RAS Franchise, and 2026 Catalyst Funnel Support Buy Rating
Premium
Ratings
Revolution Medicines: Dominant Pancreatic Cancer Position, Expanding RAS Franchise, and 2026 Catalyst Funnel Support Buy Rating
18d ago
RVMD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >